Alkermes plc announced that on December 4, 2023, following ten years of service, Nancy J. Wysenski notified the company of her decision to retire, for personal reasons, from the Company?s board of directors and from any Board leadership positions and committees on which she serves, in each case effective as of December 8, 2023. On December 7, 2023, the Board decreased the size of the Board from eleven directors to ten directors and appointed Frank Anders Wilson as the Lead Independent Director of the Board, in each case effective as of December 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.1 USD | -0.78% |
|
-3.41% | -13.12% |
06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.12% | 4.08B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes plc Announces Changes to its Board